Sucralfate tablets
Product Description
Lyrus Life Sciences
-
Country/Region:India
-
On CPHI since:2019
-
Certificates:4
-
Employees:250 - 499
Categories
Specifications
Lyrus Life Sciences
-
Country/Region:India
-
On CPHI since:2019
-
Certificates:4
-
Employees:250 - 499
More Products from Lyrus Life Sciences (3)
-
Product Methenamine Hippurate Tabs 1000 mg
Methenamine does not have antibacterial properties in an alkaline environment (pH≥6); however, in a more acidic environment (pH<6), methenamine is hydrolyzed to formaldehyde. Formaldehyde is considered to be highly bactericidal. Formaldehyde has nonspecific antibacterial activity and works by ... -
Product Metformin PR tablets
Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. -
Product Nitrofurantoin Capsules
Nitrofurantoin is reduced by bacterial enzymes to reactive intermediates.These intermediates attack bacterial ribosomal proteins, which stops protein synthesis.This also inhibits the synthesis of DNA, RNA, and cell wall proteins.Nitrofurantoin's broad-based mechanism of action makes it difficult for bacter...
Lyrus Life Sciences resources (3)
-
News MHRA approvals
MA received from MHRA for Mebeverine, Procyclidine, Nitrofurantoin Susp, Metformin XR, Metformin IR, Para Codeine tabs, Trazodone Caps, Mefenamic Acid Caps 250mg, Lymecycline Caps 408mg, Lisinopril Oral solution, -
Brochure Lyrus Life Science Brochure
Introduction:The Lyrus Life Science brochure provides a comprehensive overview of our company's capabilities, management profile, research and development strengths, and production facilities. It serves as a valuable resource to gain insights into our operations and the therapies we specialize in. At Lyrus Life Science, we are committed to developing innovative products using non-infringing technologies, revolutionizing the healthcare industry.
-
News Lyrus Receives US FDA approval for Critical UTI treatment in the US
Lyrus has received US FDA approval for our Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex®.


